Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




IVIG and Rituximab Regimen to Reduce Anti-HLA Antibodies In Renal Transplantation
Link ID 7535
Title IVIG and Rituximab Regimen to Reduce Anti-HLA Antibodies In Renal Transplantation
Url http://www.medscape.com/viewarticle/578458?src=rss
Description This video blog by Ron Shapiro, MD discusses new clinical trial data on emerging therapeutic options for highly-sensitized renal transplant candidates awaiting transplantation.
Medscape Transplantation
Category Articles > Nephrology
Keywords
Date Aug 7, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Nephrology
1. Hospitalization Discharge Diagnoses for Kidney Disease -- United States, 1980-2005
  Acute renal failure and chronic kidney failure accounted for 221,000 and 19,000 US hospitalizations in 2004, respectively. What are the national trends in kidney disease hospitalizations?
Morbidity & Mortality Weekly Report
Category:   Articles > Nephrology


2. National Kidney Foundation (NKF) 2008 Spring Clinical Meetings
  Read clinically focused news coverage of key developments from the meeting. Medscape Nephrology
Category:   Articles > Nephrology


3. Kidneys With Small Tumors May Be Suitable for Transplantation
  The availability of renal grafts for transplantation could be increased by using kidneys removed for small, incidentally detected tumors, the results of an Australian study suggest. Reuters Health Information
Category:   Articles > Nephrology


4. Prevalence And Severity Of Disordered Mineral Metabolism In Blacks With Chronic Kidney Disease
  Disorders of mineral metabolism develop early in chronic kidney disease, but it appears that Blacks with stage-5 disease have more severe secondary hyperparathyroidism than other races.
Kidney International
Category:   Articles > Nephrology


5. Open Letter to the FDA: New Drug Trials Must Be Relevant
  The insistence of the FDA that only narrowly defined regimens are allowed in the control group in prospective randomized trials for drug registration has led to many undesirable consequences.
American Journal of Transplantation
Category:   Articles > Nephrology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS